SCHEMBL1670310

SCHEMBL1670310

CC1N(C(=O)OCc2ccccc2)c2ccccc2C12CCNCC2

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.49
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43
CACNA1G O43497 1/20 0.41
CACNA1H O95180 1/20 0.41
CACNA1I Q9P0X4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
P2RX4 Q99571 2/20 0.41
P2RX1 P51575 1/20 0.40
P2RX3 P56373 1/20 0.40
GLA P06280 1/20 0.39
CTRB1 P17538 1/20 0.39
TACR1 P25103 1/20 0.38
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16539832 0.85 HTR2C (0.43) HTR2CNPC1RAB9ASMN1; SMN2GAA
SCHEMBL6649033 0.82 HTR2C (0.40) HTR2CNPC1RAB9ASMN1; SMN2GAA
SCHEMBL8707482 0.74 HTR2C (0.38) HTR2CNPC1RAB9ASMN1; SMN2GAA
SCHEMBL6544398 0.74 NPC1 (0.51) HTR2CNPC1RAB9ASMN1; SMN2GAA
Hydrochloric Acid SCHEMBL7565105 0.73 NPC1 (0.50) HTR2CNPC1RAB9ASMN1; SMN2GAA
SCHEMBL28648250 0.73 CTRB1 (0.48) HTR2CNPC1RAB9ASMN1; SMN2GAA
SCHEMBL27193408 0.70 HTR2C (0.51) HTR2CNPC1RAB9ASMN1; SMN2GAA
SCHEMBL14713128 0.70 SIGMAR1 (0.36) HTR2CKDM1A
SCHEMBL7711512 0.70 ENPP2 (0.54) HTR2CNPC1RAB9ASMN1; SMN2GAA
SCHEMBL2801668 0.69 NOTUM (0.40) MAPK1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015028960-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVES AS GPR AGONISTS AND USES THEREOF Piramal Enterprises Limited (IN) 2015-03-05 WO disclosed
EP-2488500-A1 SPIROPIPERIDINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF FOR TREATING DIABETES Eli Lilly and Company (US) 2012-08-22 EP disclosed
WO-2011046851-A1 SPIROPIPERIDINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF FOR TREATING DIABETES ELI LILLY AND COMPANY (US) 2011-04-21 WO disclosed